Swiss National Bank’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,124
| Closed | -$226K | – | 2583 |
|
|
2023
Q3 | $226K | Hold |
7,124
| – | – | ﹤0.01% | 2600 |
|
|
2023
Q2 | $586K | Buy |
7,124
+232
| +3% | +$19.1K | ﹤0.01% | 2511 |
|
|
2023
Q1 | $708K | Sell |
6,892
-616
| -8% | -$63.3K | ﹤0.01% | 2421 |
|
|
2022
Q4 | $1.1M | Buy |
7,508
+148
| +2% | +$21.7K | ﹤0.01% | 2293 |
|
|
2022
Q3 | $1.24M | Buy |
7,360
+240
| +3% | +$40.6K | ﹤0.01% | 2206 |
|
|
2022
Q2 | $822K | Buy |
7,120
+1,680
| +31% | +$194K | ﹤0.01% | 2464 |
|
|
2022
Q1 | $543K | Buy |
5,440
+384
| +8% | +$38.3K | ﹤0.01% | 2584 |
|
|
2021
Q4 | $786K | Buy |
5,056
+136
| +3% | +$21.1K | ﹤0.01% | 2554 |
|
|
2021
Q3 | $1.16M | Buy |
4,920
+88
| +2% | +$20.7K | ﹤0.01% | 2363 |
|
|
2021
Q2 | $1.64M | Sell |
4,832
-180
| -4% | -$61.1K | ﹤0.01% | 2234 |
|
|
2021
Q1 | $2.03M | Buy |
5,012
+64
| +1% | +$25.9K | ﹤0.01% | 1990 |
|
|
2020
Q4 | $3.29M | Buy |
4,948
+316
| +7% | +$210K | ﹤0.01% | 1620 |
|
|
2020
Q3 | $2.16M | Buy |
4,632
+148
| +3% | +$68.9K | ﹤0.01% | 1680 |
|
|
2020
Q2 | $2.62M | Buy |
+4,484
| New | +$2.62M | ﹤0.01% | 1554 |
|